OPD-5

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameOPD-5
Drug Alias NameOPD-5
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechia
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOncopeptides Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOncopeptides Ab
Active IndicationsN/A
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A